Company performance
Add to research
Current Price
as of Mar 13, 2025$0.45
P/E Ratio
N/A
Market Cap
$7.3M
- KOSS
Description
Add to research
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
Metrics
Add to research
Overview
- HQSan Francisco, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerJAGX
- Price$0.449-6.46%
Trading Information
- Market cap$7.30M
- Float82.88%
- Average Daily Volume (1m)419,896
- Average Daily Volume (3m)426,190
- EPS-$16.10
Company
- Revenue$10.48M
- Rev growth (1yr)10.49%
- Net income-$9.85M
- Gross margin63.42%
- EBITDA margin-214.48%
- EBITDA-$6.67M
- EV$35.62M
- EV/Revenue3.40
- P/EN/A
- P/S0.40
- P/B0.34
- Debt/Equity212.89
Documents
Add to research
SEC Filings
Earnings Calls